Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2008 Nov 4.
Published in final edited form as: Biochemistry. 2007 May 1;46(20):6043–6049. doi: 10.1021/bi7001532

THERMAL TRANSITIONS IN HUMAN VERY LOW-DENSITY LIPOPROTEIN: FUSION, RUPTURE AND DISSOCIATION OF HDL-LIKE PARTICLES

Madhumita Guha 1, Cheryl England 1, Haya Herscovitz 1, Olga Gursky 1
PMCID: PMC2577769  NIHMSID: NIHMS62324  PMID: 17469851

Abstract

Very low-density lipoproteins (VLDL) are metabolic precursors of low-density lipoproteins (LDL) and a risk factor for atherosclerosis. Human VLDL are heterogeneous complexes containing triacylglyceride-rich apolar lipid core and polar surface comprised of phospholipids, a non-exchangeable apolipoprotein B, and exchangeable apolipoproteins E and Cs. We report the first stability study of VLDL. Circular dichroism and turbidity data reveal an irreversible heat-induced VLDL transition that involves formation of larger particles and repacking of apolar lipids but no global protein unfolding. Heating rate effect on the melting temperature indicates a kinetically controlled reaction with high activation energy, Ea. Arrhenius analysis of the turbidity data reveals two kinetic phases with Ea=53±7 kcal/mol that correspond to distinct morphological transitions observed by electron microscopy. One transition involves VLDL fusion, partial rupture and dissociation of small spherical particles (d=7–15 nm), and another involves complete lipoprotein disintegration and lipid coalescence into droplets accompanied by dissociation of apolipoprotein B. The small particles, which are unique to VLDL denaturation, are comparable in size and density to high-density lipoproteins (HDL); they have apolar lipid core and polar surface comprised of exchangeable apolipoproteins (E and possibly Cs) and phospholipids. We conclude that, similar to HDL and LDL, VLDL are stabilized by kinetic barriers that prevent particle fusion and rupture and decelerate spontaneous inter-conversion among lipoprotein classes and subclasses. In addition to fusion, VLDL disruption involves transient formation of HDL-like particles that may mimic protein exchange among VLDL and HDL pools in plasma.


Plasma lipoproteins, including high-, low-, intermediate-, and very-low density lipoproteins (HDL, LDL, IDL and VLDL), are macromolecular complexes of lipids and proteins (termed apolipoproteins) that mediate lipid transport and metabolism and are central in the development of coronary artery disease. HDL are anti-atherogenic, LDL are pro-atherogenic, and VLDL are not only direct metabolic precursors of LDL but also an independent risk factor for atherosclerosis (18). VLDL are the major carriers of triacylglycerides (TG) in plasma. Human VLDL form heterogeneous population of spherical particles that contain apolar core comprised mainly of TG and cholesterol esters (CE) and polar surface comprised of cholesterol-containing phospholipid monolayer and proteins. The proteins include one copy of non-exchangeable apolipoprotein B (apoB, 550 kD) and multiple copies of exchangeable apolipoproteins, mainly apoE (34 kD) and apoCs (6–9 kD), that comprise over 50% of the total VLDL protein content. Metabolic remodeling by lipolytic enzymes converts VLDL into LDL that contain apoB as their sole protein, while the dissociated apoE and apoCs enter the HDL pool (2,4). Structural and stability properties of HDL and LDL have been intensely investigated by spectroscopic and calorimetric methods ((911) and refs. therein), yet structural studies of VLDL have been limited to non-denaturing conditions (1214). Here we report the first stability study of human VLDL.

Our recent thermal and chemical denaturation analyses have shown that HDL and LDL are stabilized by kinetic barriers, and have revealed distinct kinetic steps in the disruption of these lipoproteins (911). The first step involves partial protein dissociation and lipoprotein fusion that compensates for the particle surface depletion of the protein moiety; the next step involves additional protein dissociation leading to lipoprotein rupture and release of the apolar core. These results prompted us to propose that kinetic barriers associated with particle fusion and rupture provide a universal natural strategy for lipoprotein stabilization and are important modulators of lipoprotein metabolism (911).

Now we test the hypothesis that, similar to HDL and LDL, the structural stability of VLDL is determined by kinetic barriers. However, vast differences in size and composition of HDL (that range in diameter from d~7–15 nm and contain only exchangeable proteins), LDL (d~22 nm, contain only non-exchangeable apoB) and VLDL (d=40–100 nm, contain both exchangeable and non-exchangeable proteins) are expected to result in distinctly different morphological transitions in these lipoproteins. In fact, clear differences were observed in the denaturation pathways of HDL and LDL. HDL denaturation involves formation of enlarged particles that are products of lipoprotein fusion and rupture and may mimic HDL fusion by plasma factors (10,11,15); in contrast, LDL denaturation involves not only formation of larger particles but also transient formation of smaller LDL-like particles that may resemble small dense LDL in plasma (11).

To test, for the first time, the heat-induced structural transitions in VLDL, we analyze thermal denaturation of VLDL from normolipidemic human plasma. The results establish the kinetic mechanism of VLDL stabilization and show that thermal denaturation of VLDL involves not only irreversible fusion and rupture but also transient formation of small spherical HDL-like particles. These particles may mimic the mode of protein and lipid exchange among HDL and VLDL pools in plasma.

MATERIALS AND METHODS

Sample preparation

VLDL from six healthy volunteer donors were used. Single-donor VLDL were isolated from EDTA-treated plasma by density gradient ultracentrifugation in the density range 0.94–1.006 g/ml (16); total VLDL migrated as a single band on agarose gel. Total VLDL were ultracentrifuged for 30 min at 40,000 rpm, 4 °C and the clear fraction comprising mainly VLDL2 subclass was collected and used to record the data shown in this work.; similar data were recorded from total VLDL (not shown), suggesting that VLDL heterogeneity does not affect the key conclusions of this study. VLDL2 stock solution of 1–2.5 mg/ml protein concentration (measured by modified Lowry assay (17)) was extensively dialyzed against the standard buffer used throughout this study (10 mM Na phosphate, 0.25 mM EDTA, 0.02% sodium azide, pH 7.6). The stock solution was stored in the dark at 4 °C and was used in 4 weeks during which no protein degradation was detected by sodium dodecyl sulfate (SDS) polyacrylamide gradient gel electrophoresis (PAGE) and no changes in the protein secondary structure or lipoprotein stability were observed by circular dichroism (CD) and turbidity.

Circular dichroism and turbidity

CD and turbidity data were recorded using AVIV-215 or AVIV-62DS spectrometers with thermoelectric temperature control. Heat-induced turbidity changes were monitored by measuring dynode voltage, V, in CD experiments as described (9,18). CD spectra were recorded with 1 nm increment, 15–20 s/nm accumulation time from degassed VLDL solutions of 0.1–0.15 mg/ml protein concentrations using 0.5–2 mm path length closed cells for far-UV CD (185–250 nm) or of 0.5–0.6 mg/ml protein concentrations using 5 mm path length cell for near-UV/visible CD (250–500 nm). Far-UV CD data were normalized to protein concentration and expressed as molar residue ellipticity [Θ] that was calculated assuming the mean residue weight of 113. In the melting experiments, CD and urbidity data, Θ(T) and V(T), were recorded simultaneously at 220 or 320 nm during sample heating and consecutive cooling from 25–98 °C at a constant rate of 80 or 10 °C/h. No changes in the sample volume or protein concentration were detected after heating and cooling. In the kinetic temperature-jump (T-jump) experiments, the sample temperature was rapidly increased at t=0 from 25 °C to a higher constant value, and the denaturation time course was monitored by CD and turbidity. Data analysis was carried out using an Arrhenius model as described (9). Briefly, kinetic data V220(t) recorded at each temperature were approximated by a multi-exponential:

V220(t)=A1exp(τ1/t)+A2exp(τ2/t)+

Here, A1 and A2 are the amplitudes of the kinetic phases, τ1 and τ2 are the exponential relaxation times that are inverse of the reaction rates, k=1/τ. Since VLDL denaturation is irreversible, the reaction rate is equivalent to the denaturation rate. The relaxation times τ(T) were measured in T-jumps from 25 °C to several higher temperatures (75–95 °C), and the activation energy (enthalpy) Ea for each kinetic phase was determined from the slope of the corresponding Arrhenius plot, lnτ versus 1/T.

Negative staining electron microscopy

VLDL subjected to various thermal treatments were visualized at 25 °C by negative staining electron microscopy (EM) using a CM12 transmission electron microscope (Philips Electron Optics) as described (9,10). Particle size analysis was carried out in EXCEL using 300– 450 particles per image.

Biochemical analysis of VLDL denaturation products

VLDL sample was incubated at 83 °C and the aliquots taken after 0–120 min of incubation were analyzed by non-denaturing PAGE and Western blotting. Particle diameters assessed from non-denaturing PAGE (4–20%) were in good agreement with EM measurements.

For immunoblotting, the samples were subjected to non-denaturing PAGE, transferred to polyvinylidene fluoride membrane and probed with primary antibodies to apoE (Chemicon) and apoB using both monoclonal antibody 1D1 (from Lipoprotein and Atherosclerosis Research Group, University of Ottawa Heart Institute) and polyclonal goat (Biodesign) and rabbit antibodies (custom-made by Sigma). The blots were probed with horseradish peroxidase-conjugated secondary antibodies (Sigma) and were visualized using an enhanced chemiluminescent system (Perkin Elmer).

To analyze the composition of the small particles transiently formed at high temperatures, VLDL stock solution was incubated at 83 °C for 15 min and the bottom fraction containing mainly the small dense particles (as indicated by negative-staining EM) was isolated by 20–30 min centrifugation at 13,000 rpm (Biofuge, Thermo).

For protein analysis, the particles from this bottom fraction were delipidated by isopropanol and subjected to gradient SDS PAGE. For lipid analysis, the lipids were extracted with 2:1 chloroform: methanol (19) and analyzed by thin-layer chromatography (TLC) using hexane: ether: acetic acid (70:30:1) or chloroform: methanol: water: acidic acid (65:25:4:1) to separate neutral and polar lipids, respectively. Lipids were also quantified by colorimetric methods (2023).

For density measurements, the density of the bottom fraction was adjusted to 1.25 g/ml with solid KBr, overlaid with 1.068 g/ml KBr solution and spun in an SW60 rotor at 52,000 rpm for 22 h. Fractions were collected from the top and their density was determined by refractometry (ABBE, Leica). Aliquots from each fraction were analyzed by negative-staining EM.

All experiments in this study were repeated 3–8 times to ensure reproducibility.

RESULTS

To assess the effects of heating on the protein secondary structure, far-UV CD spectra were recorded from VLDL samples that were heated and cooled from 25–98 °C. Figure 1A shows the spectra of VLDL recorded at 25 °C before and after heating to 98 °C. The spectrum of intact VLDL is consistent with the earlier report (12) and indicates a mixture of α-helix and β-sheet. It partially overlaps the spectrum of heated VLDL that is cut off near 195 nm due to an irreversible heat-induced increase in turbidity (described below). This spectral overlap suggests that the secondary structure of VLDL proteins is partially retained after heating to 98 °C.

Figure 1.

Figure 1

Effect of heating on the protein secondary structure in VLDL. A - Far-UV CD spectra recorded at 25 °C of intact VLDL and of VLDL that have been heated and cooled from 25–98 °C at 80 °C/h. B - CD melting curves at 220 nm recorded upon heating and cooling of VLDL at a rate of 80 °C/h (black) or 10 °C/h (gray). The data in A, B were recorded from VLDL samples of 0.15 mg/ml protein concentration in standard buffer (10 mM Na phosphate, pH 7.6).

To monitor the secondary structure as a function of temperature, CD signal at 220 nm, Θ220(T), was recorded during VLDL heating and cooling at a rate of 10 or 80 °C/h. Heating to less than 80 °C leads to a gradual reduction in the CD amplitude that is reversible upon cooling, as evident from the close superimposition of the heating and cooling curves (not shown); similar changes in far-UV CD were observed in a limited temperature range in plasma HDL and LDL and were attributed to secondary structural relaxation rather than global protein unfolding (11,15). VLDL heating to higher temperatures leads to a small but significant increase in the negative CD above 80 °C (Fig. 1B, upper lines). This CD change may not reflect secondary structure unfolding (which leads to a reduction rather than an increase in the Θ220 amplitude) and may result, at least in part, from a shoulder of a large negative CD peak at 320 nm that is observed in VLDL at these temperatures and is described below. This high-temperature transition is irreversible, as indicated by non-coincident heating and cooling data in Fig. 1. Furthermore, the onset of this transition shifts to lower temperatures at slower scan rates (Fig. 1, double arrow). Such a scan rate effect is a hallmark of a kinetically controlled reaction with high activation energy (23) that is typical of lipoprotein denaturation (911).

To elucidate the origin of this high-temperature transition, near-UV/visible CD spectra of VLDL were recorded at 25 °C before and after heating to 98 °C. In contrast to intact VLDL, the spectrum of heated VLDL shows a large negative CD peak centered at 320 nm (Fig. 2A). A similar irreversible heat-induced change in near-UV/visible CD was observed in LDL and was attributed to re-packing of apolar lipids upon lipoprotein rupture and release of the apolar core (11). In fact, protein contribution to CD may be large only at λ<300 nm; therefore, the CD peak at 320 nm is probably dominated by the contribution from apolar lipids such as carotenoids, TG and CE, which are the only VLDL moieties that exhibit large induced CD at these wavelengths (2528). Thus, the large irreversible heat-induced changes in near-UV/visible CD of VLDL suggest re-packing of apolar lipids due to lipoprotein rupture.

Figure 2.

Figure 2

Thermal transition in VLDL monitored by near-UV/visible CD and turbidity. A - CD spectra recorded at 25 °C of intact VLDL and of VLDL that have been heated and cooled from 25–98 °C at 80 °C/h rate. B, C – Melting data Θ320(T) and V320 (T) recorded at 320 nm by CD and turbidity at a scan rate of 80 °C/h (black) or 10 °C /h (gray). D - CD melting data recorded at 320 nm, 80 °C/h scan rate, from VLDL samples of varying protein concentrations (indicated on the lines). Cell path length in A–D is 5 mm.

To test this hypothesis, we correlated the heat-induced changes in near-UV/visible CD (that report on lipid re-packing) and turbidity (that report on changes in the particle size and refractive index). To do so, we measured dynode voltage, V, in CD experiments as described (9,18). The melting data Θ320(T) and V320(T) in Fig. 2B, C were recorded simultaneously at 320 nm during VLDL heating and cooling at a rate of 10 to 80 °C/h. The heating curves in Fig. 2B show a large cooperative increase in the negative CD signal; heating to higher temperatures leads to a small reduction in this negative CD that is due to lipid phase separation. Importantly, the large increase in the CD amplitude is accompanied by a large sigmoidal increase in turbidity (Fig. 2C), suggesting that lipid repacking is accompanied by an increase in the particle size. Closer inspection of the heating curves in Fig. 2B, C shows that the increase in turbidity precedes the CD changes by about 5 °C, suggesting that the increase in the particle size precedes re-packing of apolar lipids; this may be due to VLDL fusion preceding particle rupture. Both CD and turbidity changes are irreversible, as indicated by non-coincident heating and cooling data in Fig. 2B, C. Moreover, both CD and turbidity heating curves shift to lower temperature by about 6 °C upon reduction in the scan rate from 80 to 10 °C/h (Fig. 2B, C), indicating high activation energy of the transition (9,24). Taken together, these results demonstrate that VLDL heating above 80 °C leads to an irreversible kinetically controlled transition that involves formation of larger particles (indicated by turbidity) followed by re-packing of apolar lipids (indicated by CD at 320 nm).

Formation of larger particles upon heating must be a high-order reaction. To test the concentration-dependence of this reaction, we recorded CD and turbidity melting data from VLDL samples of various concentrations under otherwise identical conditions. Turbidity heating data V320(T) in Fig. 2D, which were recorded at a rate of 80 °C/h from VLDL solutions of 0.11–0.56 mg/ml protein concentration, show that increase in VLDL concentration leads to an increased amplitude and apparent cooperativity of the transition but has no large effect on its onset temperature.

To assess the kinetics of VLDL denaturation, we monitored the time course of the turbidity changes in T-jumps from 25 °C to higher temperatures (75–95 °C). Fig. 3A shows V220(t) data recorded from VLDL solutions of 0.15 mg/ml protein concentration. Data fitting by double-exponentials (solid lines in Fig. 3A) suggests two distinct denaturation phases. The Arrhenius plots for these two phases are linear and have similar slopes that correspond to the activation energy Ea=53±7 kcal/mol (Fig. 3B). The error in this estimate incorporates the fitting errors and the discrepancies among the data sets recorded from different VLDL pools.

Figure 3.

Figure 3

Kinetic analysis of VLDL heat denaturation. A – Time course of thermal denaturation monitored by turbidity at 220 nm, V220(t), in temperature jumps from 25 °C to higher temperatures (indicated on the lines). VLDL protein concentration is 0.15 mg/ml. Data fitting by double-exponentials (solid lines) suggests two kinetic phases. B – Arrhenius analysis of the V220(t) data in panel A (open symbols). The Arrhenius plots for the two kinetic phases have similar slopes that correspond to activation energy Ea=53±7 kcal/mol. At higher VLDL concentrations (0.56 mg/ml protein), V220(t) data are well-approximated by mono-exponentials corresponding to the fast kinetic phase (solid symbols).

Similar T-jump data recorded from samples of higher VLDL concentration (0.5–0.6 mg/ml protein, data not shown) are well-approximated by single-exponentials that correspond to the faster kinetic phase, as illustrated by the overlapping Arrhenius plots (Fig. 3B, closed and open symbols). Thus, increasing VLDL concentration causes no large changes in the Arrhenius activation energy Ea but accelerates the slow phase, resulting in a single-phase reaction.

The two-exponential denaturation kinetics observed at low VLDL concentrations may reflect sample heterogeneity or distinct reaction steps. The former is unlikely, since the highly heterogeneous total VLDL pool shows similar two-phase kinetics to the more homogeneous VLDL2 subclass isolated from this pool. Alternatively, the two-exponential kinetics may reflect two phases corresponding to distinct morphologic transitions in VLDL. To identify these transitions, we used negative staining EM to visualize the particles at various stages of thermal denaturation.

In one series of experiments, VLDL sample of 0.15 mg/ml protein concentration was heated at a constant rate of 80 °C/h and the aliquots taken at several temperatures from the transition range were analyzed by EM (Fig. 2B, C). Fig. 4A shows intact particles ranging in diameter from 40–60 nm that is typical of human VLDL2. Fig. 4B shows that heating to 83 °C leads to an increase in the particle size that is consistent with the increased turbidity (Fig. 2C) and occurs via two mechanisms. First, round-shaped lipoprotein-like particles of larger diameters are observed that are apparent products of VLDL fusion; also, clusters of aggregated particles are seen that contain intact-size and fused VLDL along with occasional lipid droplets that may be formed by coalescence of apolar core lipids released from ruptured VLDL (Fig. 4B). Similarly, heat- or denaturant-induced lipoprotein fusion and rupture were observed in plasma HDL and LDL (10,11,15). Fig. 4C shows that heating to 90 °C leads to conversion of all VLDL-like particles into large lipid droplets, suggesting extensive rupture; these results are in good agreement with the CD and turbidity heating curves in Fig. 2B, C and show that VLDL fusion (which leads to the initial increase in the particle size observed by turbidity) is followed by VLDL rupture and re-packing of apolar lipids (observed by CD). Remarkably, small round-shaped particles are also formed at 90 °C (Fig. 4C). The diameters of these particles range from 8–13 nm (which is similar to plasma HDL), with an average diameter <d>=10–12 nm observed for lipoproteins from different plasma pools (Fig. 4E). Formation of such HDL-size particles has never before been reported in the lipoprotein denaturation studies. Finally, heating to 98 °C, i.e. to the completion of the CD and turbidity transition (black lines in Fig. 2B, C), leads to a complete conversion of all lipoprotein-like particles into lipid droplets and to the appearance of thin density streaks (Fig. 4D) whose size and morphology are consistent with dissociated apoB (29); similar density streaks have been observed at the final stage of thermal disruption of LDL (11). Thus, similar to HDL and LDL, VLDL heating leads to lipoprotein fusion, rupture and protein dissociation. In addition, transient dissociation of small HDL-size particles is observed that is unique to VLDL (Fig. 4C).

Figure 4.

Figure 4

Heat-induced morphological transitions in VLDL monitored by negative staining electron microscopy. VLDL sample of 0.15 mg/ml protein concentration was heated at 80 °C/h; sample aliquots were taken at several temperatures from the transition range and were visualized by EM. Intact VLDL (A) and VLDL heated to 83 °C (B), 87 °C (C) and 98 °C (D) are shown; E - size histogram for the small particles observed in panel C. Fused VLDL (black arrowheads), lipid droplets (white arrowheads), and density streaks consistent with dissociated apoB (white arrows) are indicated.

In another series of experiments, VLDL sample of 0.15 mg/ml protein concentration was subjected to a T-jump to 83 °C; sample aliquots were taken after incubation at 83 °C for up to 120 min and were visualized by negative staining EM. Incubation for 3 min led to extensive fusion and partial aggregation of VLDL, similar to that observed in Fig. 4B. Incubation for 10 min (which corresponds to the exponential relaxation time τfast for the fast kinetic phase determined from the T-jump turbidity data) resulted in extensive VLDL rupture and dissociation of small HDL-size particles, similar to those in Fig. 4C. Incubation for 120 min (which corresponds to the exponential relaxation time τslow for the slow kinetic phase) leads to coalescence of all lipoprotein-like particles into large lipid droplets and to formation of density streaks that are consistent with dissociated apoB, similar to those seen in Fig. 4D. Thus, the correlation of the EM and turbidity data suggests that the faster kinetic phase in VLDL denaturation involves VLDL fusion, partial rupture and release of small HDL-size particles, while the slower phase involves complete lipoprotein disintegration and lipid coalescence into large droplets, along with apparent dissociation of apoB.

To further analyze the nature of the transiently occurring HDL-size particles, VLDL samples of 0.5–0.6 mg/ml protein concentration were subjected to a T-jump to 83 °C and the aliquots taken during the first hour of incubation at 83 °C were analyzed by non-denaturing PAGE. At high sample concentrations used in these experiments, VLDL denaturation shows only one relatively fast kinetic phase (Fig. 3B) with relaxation time τ1=5–10 min for VLDL from different plasma pools. Non-denaturing PAGE shows that the band corresponding to intact VLDL gradually disappears during the first 30 min of incubation (Fig. 5A), which is consistent with VLDL fusion, aggregation and rupture observed by EM at this temperature (Fig. 4B). In addition, formation of small HDL-size particles (d~9 nm) is observed after 5–25 min incubation (which encompasses τfast=10 min for this sample); this result is consistent with the average size of the small particles determined by EM (Fig. 4C). After prolonged incubation (30 min or more), the band corresponding to these small particles disappears (Fig. 5A), which is consistent with disappearance of HDL-size particles observed by EM upon prolonged incubation at 83 °C or gradual heating above 90 °C (Fig. 4D). Taken together, our kinetic studies by turbidity, EM and non-denaturing PAGE indicate that the transient formation of HDL-size particles occurs during the fast kinetic phase of VLDL denaturation.

Figure 5.

Figure 5

Time course of thermal disruption of VLDL monitored by non-denaturing PAGE and Western blotting. VLDL samples of 0.56 mg/ml protein concentration were incubated at 83 °C for 120 min. Sample aliquots were taken after different incubation times (indicated on the lanes in min); 0 indicates intact VLDL. Incubation for over 30 min led to no additional changes in the data (not shown). Non-denaturing PAGE (A) and a similar PAGE followed by Western blotting using antibodies for apoE (B) or apoB (C) are shown. The bands corresponding to intact VLDL and to HDL-size particles are indicated. Single-donor VLDL from donor A were used to record the data in panel A, and from donor B to record the data in panels B, C; these VLDL showed different relaxation times for the first kinetic phase during which HDL-size particles are formed (τ1=15 min for donor A and 8 min for donor B), which explains slower reaction time course in panel A as compared to panels B, C.

The protein composition of the total products of VLDL denaturation was assessed as follows. VLDL at various stages of thermal denaturation at 83 °C were subjected to non-denaturing PAGE followed by immunoblotting using antibodies to apoE and apoB. The results in Fig. 5B, C clearly show that, in contrast to intact VLDL that contain both exchangeable (apoE) and non-exchangeable proteins (apoB), the small particles dissociated from VLDL contain apoE but no apoB.

Protein composition of the HDL-size particles was also analyzed by SDS PAGE. VLDL were incubated for up to 15 min at 83 °C to maximize the population of the small particles, followed by centrifugation at 13,000 rpm for 20–30 min. The bottom fraction contained mainly HDL-size particles with trace amounts of fused VLDL (as indicated by EM, data not shown); this fraction was used for the biochemical analysis. SDS PAGE analysis of this fraction shows that it contains apoE and apoCs but no apoB (Fig. 6). Thus, the data in Fig. 5, Fig. 6 consistently show that, similar to HDL but in contrast to intact VLDL, the small particles dissociated from VLDL contain only exchangeable proteins (apoE and possibly apoCs) but no apoB.

Figure 6.

Figure 6

Protein composition of intact VLDL and of the small HDL-size particles transiently formed during VLDL heating. The particles were obtained by VLDL incubation at 83 °C for 15 min followed by cooling to 22 °C and centrifugation at 13,000 rpm for 30 min. SDS PAGE of these particles and of intact VLDL is shown. The bands corresponding to the major VLDL proteins (apoB, apoE and apoCs) are indicated.

Lipid composition of the bottom fraction was assessed by TLC and by enzymatic assays. The results showed polar (phospholipids, unesterified cholesterol) and apolar lipids (CE and TG) but no lyso-phospholipids (and hence no lipolysis). Consequently, the HDL-size particles contain polar surface and apolar core and thereby resemble spherical lipoproteins. Spherical shape is also consistent with exclusively round-shape appearance of the HDL-size particles observed by negative staining EM (Fig. 4C).

Importantly, density gradient centrifugation followed by EM analysis of individual fractions showed the presence of exclusively HDL-size particles in the density range from 1.109–1.186 g/ml, which is similar to the density of plasma HDL. Low particle yield precluded accurate lipid and protein quantification in these density fractions.

In summary, the small particles dissociated from VLDL resemble mature plasma HDL in their spherical shape, size, density and the presence of only exchangeable proteins on their surface.

DISCUSSION

The results reported here confirm that the kinetic mechanism provides a universal natural strategy for lipoprotein stabilization. They demonstrate that, similar to HDL and LDL, VLDL are stabilized by free energy barriers that decelerate morphologic lipoprotein transitions such as fusion and rupture. In fact, turbidity data in Fig. 3A show that, in a near-neutral low-salt solution at 78–95 °C, these VLDL transitions occur on a timescale of hours to minutes. Linear extrapolation of the Arrhenius plots in Fig. 3B to 37 °C suggests that, at near-physiologic temperatures, spontaneous VLDL fusion and rupture occur on a time scale of years, much longer than the lipoprotein lifetime in plasma (days). Although the rates of lipoprotein transitions may be affected by solvent ionic conditions (15) and other plasma factors, it is clear that spontaneous remodeling and fusion of VLDL under physiologic conditions is extremely slow and thus is subject to enzymatic control.

Interestingly, heating induces not only fusion and rupture of VLDL but also transient dissociation of HDL-size particles. Similar to mature HDL, these particles have an apolar core of CE and TG and polar surface comprised of phospholipids and exchangeable apolipoproteins. In contrast to HDL, these particles contain apoE and possibly apoCs but no apoA-I. This may explain relatively low stability of these small particles that disappear (apparently due to rupture) upon fast heating beyond 90 °C or prolonged incubation at 83 °C (Fig. 4D); in contrast, plasma HDL are highly thermostable and remain intact under these conditions (15). Thus, the small particles dissociated from VLDL upon heating are similar to mature HDL in size, density and spherical morphology but are different in their protein composition and stability.

We propose that the HDL-like particles dissociated from VLDL may mimic aspects of apoE transfer between TG-rich lipoproteins and HDL in plasma. The key steps in the metabolism of TG-rich lipoproteins include VLDL conversion to IDL by lipoprotein lipase followed by IDL to LDL conversion by hepatic lipase. In these reactions, the particle core shrinks due to TG lipolysis and the excess surface materials (exchangeable apolipoproteins and polar lipids) transfer to HDL ((30, 31) and refs. therein). Transfer of apoE from TG-rich lipoproteins to HDL in the fasted state occurs via the lipid-bound protein form that resembles discoidal or spherical HDL and contributes to the significant fraction of plasma HDL (~10%) that contain apoE but no apoA-I ((32) and refs. therein). In plasma, apoE facilitates CE core expansion in HDL and thereby plays an important role in HDL metabolism, particularly in case of cholesterol ester transfer protein deficiency (33,34). Thus, apoE-containing HDL, which may be generated during lipolysis of TG-rich proteins, are important players in lipoprotein metabolism.

ApoE-containing plasma HDL, which belong to HDL2 subclass (d=9–17 nm) (34,35), are similar in size to apoE-containing HDL-like particles observed in this work (Fig. 4C, E; Fig. 5). Formation of these small particles follows heat-induced VLDL fusion (Fig. 4B, C) and thereby provides a mechanism for removing excess surface material from the fused particles. Thus, different modes of VLDL perturbation (such as lipase-mediated TG hydrolysis or heat-induced VLDL fusion) may lead to transient formation of similar apoE-containing HDL-like particles.

Earlier studies of HDL and LDL have shown that thermal and solute-induced perturbations may mimic aspects of enzymatic lipoprotein remodeling such as particle fusion, apolipoprotein dissociation and phospholipid transfer (10,11,36,37). The results reported here extend this notion to VLDL and suggest that thermal perturbation of VLDL mimics aspects of protein and lipid transfer among TG-rich lipoproteins and HDL pools in plasma.

ACKNOWLEDGEMENT

We are indebted to Michael Gigliotti for help with biochemical assays, to Donald L. Gantz for help with electron microscopy, to Dr. Shobini Jayaraman and Sangeeta Benjwal for experimental help, and to Dr. David Atkinson for invaluable advice.

Abbreviations used

VLDL

very low-density lipoprotein

LDL

low-density lipoprotein

HDL

high-density lipoprotein

apoB

apolipoprotein B

apoE

apolipoprotein E

apoCs

apolipoproteins C-I, C-II, and C-III

TG

triacylglyceride

CE

cholesterol ester

CD

circular dichroism

T-jump

temperature jump

EM

electron microscopy

SDS

sodium dodecyl sulfate

PAGE

polyacrylamide gel electrophoresis

TLC

thin-layer chromatography

Footnotes

This work was supported by the National Institutes of Health grants GM067260 and HL026355.

REFERENCES

  • 1.Anber V, Millar JS, McConnell M, Shepherd J, Packard CJ. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans. Arterioscler. Thromb. Vasc. Biol. 1997;17(11):2507–2514. doi: 10.1161/01.atv.17.11.2507. [DOI] [PubMed] [Google Scholar]
  • 2.Demant T, Packard C. In vivo studies of VLDL metabolism and LDL heterogeneity. Eur. Heart J. 1998;19 Suppl. H:7–10. [PubMed] [Google Scholar]
  • 3.Krauss RM. Atherogenicity of triglyceride-rich lipoproteins. Am. J. Cardiol. 1998;81(4A):13B–17B. doi: 10.1016/s0002-9149(98)00032-0. [DOI] [PubMed] [Google Scholar]
  • 4.Shelness GS, Sellers JA. Very-low-density lipoprotein assembly and secretion. Curr. Opin. Lipidol. 2001;12(2):151–157. doi: 10.1097/00041433-200104000-00008. [DOI] [PubMed] [Google Scholar]
  • 5.Skalen K, Gustafsson M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL, Boren J. Sub-endothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 2002;417:750–754. doi: 10.1038/nature00804. [DOI] [PubMed] [Google Scholar]
  • 6.Segrest JP. The role of non-LDL:non-HDL particles in atherosclerosis. Curr. Diab. Rep. 2002;2(3):282–288. doi: 10.1007/s11892-002-0096-0. [DOI] [PubMed] [Google Scholar]
  • 7.Olofsson SO, Boren J. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. J. Intern. Med. 2005;258(5):395–410. doi: 10.1111/j.1365-2796.2005.01556.x. [DOI] [PubMed] [Google Scholar]
  • 8.Segrest JP, Jones MK, De Loof H, Dashti N. Structure of apolipoprotein B-100 in low density lipoproteins. J. Lipid Res. 2001;42(9):1346–1367. [PubMed] [Google Scholar]
  • 9.Gursky O, Ranjana R, Gantz DL. Complex of human apolipoprotein C-1 with phospholipid: Thermodynamic or kinetic stability? Biochemistry. 2002;41:7373–7384. doi: 10.1021/bi025588w. [DOI] [PubMed] [Google Scholar]
  • 10.Mehta R, Gantz DL, Gursky O. Human plasma high-density lipoproteins are stabilized by kinetic factors. J. Mol. Biol. 2003;328(1):183–192. doi: 10.1016/s0022-2836(03)00155-4. [DOI] [PubMed] [Google Scholar]
  • 11.Jayaraman S, Gantz DL, Gursky O. Structural basis for thermal stability of human low-density lipoprotein. Biochemistry. 2005;44(10):3965–3971. doi: 10.1021/bi047493v. [DOI] [PubMed] [Google Scholar]
  • 12.Chen GC, Kane JP. Secondary structure in very low density and intermediate density lipoproteins of human serum. J. Lipid Res. 1979;20(4):481–488. [PubMed] [Google Scholar]
  • 13.Parks JS, Atkinson D, Small DM, Rudel LL. Physical characterization of lymph chylomicra and very low density lipoproteins from nonhuman primates fed saturated dietary fat. J. Biol. Chem. 1981;256:12992–12999. [PubMed] [Google Scholar]
  • 14.Hale JE, Schroeder F. Differential scanning calorimetry and fluorescence probe investigations of very low density lipoprotein from the isolated perfused rat liver. J. Lipid Res. 1981;22:838–851. [PubMed] [Google Scholar]
  • 15.Jayaraman S, Gantz DL, Gursky O. Effects of salt on thermal stability of human plasma high-density lipoproteins. Biochemistry. 2006;45:4620–4628. doi: 10.1021/bi0524565. [DOI] [PubMed] [Google Scholar]
  • 16.Schumaker VN, Puppione DL. Sequential flotation ultracentrifugation. Methods Enzymol. 1986;128:155–170. doi: 10.1016/0076-6879(86)28066-0. [DOI] [PubMed] [Google Scholar]
  • 17.Markwell MA, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 1978;87(1):206–210. doi: 10.1016/0003-2697(78)90586-9. [DOI] [PubMed] [Google Scholar]
  • 18.Benjwal S, Verma S, Röhm KH, Gursky O. Monitoring protein aggregation during thermal unfolding in circular dichroism experiments. Protein Sci. 2006;15:635–639. doi: 10.1110/ps.051917406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957;226(1):497–509. [PubMed] [Google Scholar]
  • 20.Bartlett GR. Phosphorus assay in column chromatography. J. Biol. Chem. 1959;234(3):466–468. [PubMed] [Google Scholar]
  • 21.Tercyak AM. Determination of cholesterol and cholesterol esters. J. Nutr. Biochem. 1991;2:281–292. [Google Scholar]
  • 22.Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem. 1982;28:2077–2080. [PubMed] [Google Scholar]
  • 23.McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 1983;29:538–542. [PubMed] [Google Scholar]
  • 24.Sanchez-Ruiz JM. Theoretical analysis of Lumry-Eyring model in differential scanning calorimetry. Biophys. J. 1992;61:921–935. doi: 10.1016/S0006-3495(92)81899-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Chen GC, Kane JP. Contribution of carotenoids to the optical activity of human serum low-density lipoprotein. Biochemistry. 1974;13(6):4706–4712. doi: 10.1021/bi00713a023. [DOI] [PubMed] [Google Scholar]
  • 26.Sklar LA, Craig IF, Pownall HJ. Induced circular dichroism of incorporated fluorescent cholesteryl esters and polar lipids as a probe of human serum low density lipoprotein structure and melting. J. Biol. Chem. 1981;256(9):4286–4292. [PubMed] [Google Scholar]
  • 27.Yeagle PL, Bensen J, Greco M, Arena C. Cholesterol behavior in human serum lipoproteins. Biochemistry. 1982;21(6):1249–1254. doi: 10.1021/bi00535a022. [DOI] [PubMed] [Google Scholar]
  • 28.Chen GC, Chapman MJ, Kane JP. Secondary structure and thermal behavior of trypsin-treated low-density lipoproteins from human serum, studied by circular dichroism. Biochim. Biophys. Acta. 1983;754(1):51–56. doi: 10.1016/0005-2760(83)90081-4. [DOI] [PubMed] [Google Scholar]
  • 29.Gantz DL, Walsh MT, Small DM. Morphology of sodium deoxycholate-solubilized apolipoprotein B-100 using negative stain and vitreous ice electron microscopy. J. Lipid Res. 2000;41(9):1464–1472. [PubMed] [Google Scholar]
  • 30.Musliner TA, Long MD, Forte TM, Nichols AV, Gong EL, Blanche PJ, Krauss RM. Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I. J. Lipid Res. 1991;32(6):917–933. [PubMed] [Google Scholar]
  • 31.Chung BH, Tallis G, Yalamoori V, Anantharamaiah GM, Segrest JP. Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins. Arterioscler. Thromb. 1994;14(4):622–635. doi: 10.1161/01.atv.14.4.622. [DOI] [PubMed] [Google Scholar]
  • 32.Rye KA, Bright R, Psaltis M, Barter PJ. Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E. J. Lipid Res. 2006;47(5):1025–1036. doi: 10.1194/jlr.M500525-JLR200. [DOI] [PubMed] [Google Scholar]
  • 33.Matsuura F, Wang N, Chen W, Jiang XC, Tall AR. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J. Clin. Invest. 2006;116(5):1435–1442. doi: 10.1172/JCI27602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Krimbou L, Marcil M, Chiba H, Genest J., Jr Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles. J. Lipid Res. 2003;44(5):884–892. doi: 10.1194/jlr.M200273-JLR200. [DOI] [PubMed] [Google Scholar]
  • 35.Mahley RW, Huang Y, Weisgraber KH. Putting cholesterol in its place: apoE and reverse cholesterol transport. J. Clin. Invest. 2006;116(5):1226–1229. doi: 10.1172/JCI28632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Jayaraman S, Gantz DL, Gursky O. Polyethylene glycol induces fusion and destabilization of human plasma high-density lipoproteins. Biochemistry. 2004;43(18):5520–5531. doi: 10.1021/bi036274r. [DOI] [PubMed] [Google Scholar]
  • 37.Pownall HJ. Detergent-mediated phospholipidation of plasma lipoproteins increases HDL cholesterophilicity and cholesterol efflux via SR-BI. Biochemistry. 2006;45(38):11514–11522. doi: 10.1021/bi0608717. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES